Bio Medica Laboratories IPO
Bio Medica Laboratories IPO Details
Bio Medica Laboratories IPO Dates & Timeline
Tentative dates follow SEBI's T+3 listing timelineBio Medica Laboratories IPO GMP Today
All IPO GMPFinal visitor sentiment
Bio Medica Laboratories IPO Allotment Status
Check allotment on the registrar’s website or the exchange websites using your PAN or application number.
New to this? Read how to check IPO allotment status or see all IPOs awaiting allotment.
About Bio Medica Laboratories IPO
Bio Medica Laboratories is an SME IPO worth ₹52.43 crore with a price band of ₹139 per share. The issue opens on 21 May 2026 and closes on 25 May 2026. Shares are expected to list on 29 May 2026 on SME Platform.
Bio Medica Laboratories IPO: FAQs
What is the price band of Bio Medica Laboratories IPO?
The Bio Medica Laboratories IPO price band is ₹139 per share and the issue size is ₹52.43 crore.
When does Bio Medica Laboratories IPO open and close?
Bio Medica Laboratories IPO opens for subscription on Thursday, 21 May 2026 and closes on Monday, 25 May 2026. Bids are accepted until 5 PM on the closing day.
What is the Bio Medica Laboratories IPO allotment date?
The basis of allotment for Bio Medica Laboratories IPO is expected to have been finalised on Tuesday, 26 May 2026, one working day after the issue closes (SEBI T+3 timeline).
How to check Bio Medica Laboratories IPO allotment status?
Visit the registrar's allotment page, select Bio Medica Laboratories IPO and search by PAN or application number. You can also check on the IPO allotment status page or on the BSE and NSE websites.
When is Bio Medica Laboratories IPO listing date?
Bio Medica Laboratories shares listed on SME Platform on Friday, 29 May 2026.
Is Bio Medica Laboratories a mainboard or SME IPO?
Bio Medica Laboratories is an SME IPO, listing on the SME Platform platform. Individual investors must apply for at least two lots in SME IPOs.
Last updated 20 May 2026, 7:05 AM IST. GMP is unofficial and indicative; dates after the issue closes are tentative. Not investment advice.